Diffusion Pharmaceuticals Inc
9 clinical trials · Sponsor
◉ Watch Diffusion Pharmaceuticals Inc
| Record | Firm | Date |
|---|---|---|
| Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease (NCT05079126) | Diffusion Pharmaceuticals Inc | 2021-12-02 |
| Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at Altitude (NCT05036980) | Diffusion Pharmaceuticals Inc | 2021-11-09 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers (NCT04808622) | Diffusion Pharmaceuticals Inc | 2021-03-17 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects (NCT04573322) | Diffusion Pharmaceuticals Inc | 2020-09-10 |
| Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke (NCT03763929) | Diffusion Pharmaceuticals Inc | 2019-08-22 |
| Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects (NCT03393000) | Diffusion Pharmaceuticals Inc | 2018-01-16 |
Track Diffusion Pharmaceuticals Inc automatically
Every clearance here is in the API, with alerts when new ones post.